Email this article HPLC-MS/MS Method for Determining Dabigatran in Human Blood Serum
- Authors: Rodina T.A.1,2, Mel’nikov E.S.2,3, Aksenov A.A.1,3, Belkov S.A.1,2,3, Sokolov A.V.1,3, Prokof’ev A.B.1,2,3, Ramenskaya G.V.1,3
-
Affiliations:
- Scientific Center for Expert Evaluation of Medical Products, Ministry of Health of the Russian Federation
- I. V. Davydovsky Municipal Clinical Hospital, Moscow City Department of Health
- I. M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University)
- Issue: Vol 51, No 12 (2018)
- Pages: 1129-1137
- Section: Article
- URL: https://ogarev-online.ru/0091-150X/article/view/244948
- DOI: https://doi.org/10.1007/s11094-018-1753-1
- ID: 244948
Cite item
Open Access
Access granted
Subscription Access
Abstract
An HPLC-MS/MS method for determining dabigatran in human blood serum was developed. Samples were prepared by precipitation of proteins using MeOH followed by centrifugation and dilution with deionized H2O. The developed method had a simple sample-preparation procedure, short analysis time, and wide analytical range (from 1 to 1,000 ng/mL). This method was suitable for routine bioanalytical studies, in particular, therapeutic drug monitoring.
About the authors
T. A. Rodina
Scientific Center for Expert Evaluation of Medical Products, Ministry of Health of the Russian Federation; I. V. Davydovsky Municipal Clinical Hospital, Moscow City Department of Health
Email: chem@folium.ru
Russian Federation, 8/2 Petrovskii Blvd., Moscow, 127051; 11 Yauzskaya St., Moscow, 109240
E. S. Mel’nikov
I. V. Davydovsky Municipal Clinical Hospital, Moscow City Department of Health; I. M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University)
Email: chem@folium.ru
Russian Federation, 11 Yauzskaya St., Moscow, 109240; 8/2 Trubetskaya St., Moscow, 119991
A. A. Aksenov
Scientific Center for Expert Evaluation of Medical Products, Ministry of Health of the Russian Federation; I. M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University)
Email: chem@folium.ru
Russian Federation, 8/2 Petrovskii Blvd., Moscow, 127051; 8/2 Trubetskaya St., Moscow, 119991
S. A. Belkov
Scientific Center for Expert Evaluation of Medical Products, Ministry of Health of the Russian Federation; I. V. Davydovsky Municipal Clinical Hospital, Moscow City Department of Health; I. M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University)
Email: chem@folium.ru
Russian Federation, 8/2 Petrovskii Blvd., Moscow, 127051; 11 Yauzskaya St., Moscow, 109240; 8/2 Trubetskaya St., Moscow, 119991
A. V. Sokolov
Scientific Center for Expert Evaluation of Medical Products, Ministry of Health of the Russian Federation; I. M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University)
Email: chem@folium.ru
Russian Federation, 8/2 Petrovskii Blvd., Moscow, 127051; 8/2 Trubetskaya St., Moscow, 119991
A. B. Prokof’ev
Scientific Center for Expert Evaluation of Medical Products, Ministry of Health of the Russian Federation; I. V. Davydovsky Municipal Clinical Hospital, Moscow City Department of Health; I. M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University)
Email: chem@folium.ru
Russian Federation, 8/2 Petrovskii Blvd., Moscow, 127051; 11 Yauzskaya St., Moscow, 109240; 8/2 Trubetskaya St., Moscow, 119991
G. V. Ramenskaya
Scientific Center for Expert Evaluation of Medical Products, Ministry of Health of the Russian Federation; I. M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University)
Email: chem@folium.ru
Russian Federation, 8/2 Petrovskii Blvd., Moscow, 127051; 8/2 Trubetskaya St., Moscow, 119991
Supplementary files
